| 000 | 01618 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516212335.0 | ||
| 264 | 0 | _c20150831 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1477-0903 | ||
| 024 | 7 |
_a10.1177/0960327114531995 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElbe, H | |
| 245 | 0 | 0 |
_aAmelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. _h[electronic resource] |
| 260 |
_bHuman & experimental toxicology _cJan 2015 |
||
| 300 |
_a100-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aBlood Urea Nitrogen |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aMelatonin _xpharmacology |
| 650 | 0 | 4 |
_aQuercetin _xpharmacology |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xpharmacology |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 700 | 1 | _aVardi, N | |
| 700 | 1 | _aEsrefoglu, M | |
| 700 | 1 | _aAtes, B | |
| 700 | 1 | _aYologlu, S | |
| 700 | 1 | _aTaskapan, C | |
| 773 | 0 |
_tHuman & experimental toxicology _gvol. 34 _gno. 1 _gp. 100-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0960327114531995 _zAvailable from publisher's website |
| 999 |
_c23810324 _d23810324 |
||